{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:20:37Z","timestamp":1782573637938,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07596-2","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T07:10:56Z","timestamp":1759821056000},"page":"1445-1457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy"],"prefix":"10.1007","volume":"53","author":[{"given":"Riccardo","family":"Laudicella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antongiulio","family":"Faggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-666X","authenticated-orcid":false,"given":"Rexhep","family":"Durmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Salsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Modica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Urso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Maria","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Sances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rinzivillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Albertelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ferra\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Tafuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Maccauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"De Rimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Secondo","family":"Lastoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Filice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"7596_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","volume":"18","author":"DM Halperin","year":"2017","unstructured":"Halperin DM, Shen C, Dasari A, Xu Y, Chu Y, Zhou S, et al. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol. 2017;18:525\u201334. https:\/\/doi.org\/10.1016\/S1470-2045(17)30110-9.","journal-title":"Lancet Oncol"},{"key":"7596_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13146","volume":"34","author":"S Grozinsky-Glasberg","year":"2022","unstructured":"Grozinsky-Glasberg S, Davar J, Hofland J, Dobson R, Prasad V, Pascher A, et al. European neuroendocrine tumor society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease. J Neuroendocrinol. 2022;34:e13146. https:\/\/doi.org\/10.1111\/jne.13146.","journal-title":"J Neuroendocrinol"},{"issue":"9","key":"7596_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0671-0","volume":"20","author":"K Oleinikov","year":"2019","unstructured":"Oleinikov K, Avniel-Polak S, Gross DJ, Grozinsky-Glasberg S. Carcinoid syndrome: updates and review of current therapy. Curr Treat Options Oncol. 2019;20(9):70. https:\/\/doi.org\/10.1007\/s11864-019-0671-0.","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"7596_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s40618-014-0119-0","volume":"37","author":"F Grimaldi","year":"2014","unstructured":"Grimaldi F, Fazio N, Attanasio R, Frasoldati A, Papini E, Angelini F, et al. Italian association of clinical endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest. 2014;37(9):875\u2013909. https:\/\/doi.org\/10.1007\/s40618-014-0119-0.","journal-title":"J Endocrinol Invest"},{"issue":"24","key":"7596_CR5","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1002\/cncr.31079","volume":"123","author":"FM Laskaratos","year":"2017","unstructured":"Laskaratos FM, Rombouts K, Caplin M, Toumpanakis C, Thirlwell C, Mandair D. Neuroendocrine tumors and fibrosis: an unsolved mystery? Cancer. 2017;123(24):4770\u201390. https:\/\/doi.org\/10.1002\/cncr.31079.","journal-title":"Cancer"},{"key":"7596_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s11154-020-09547-8","volume":"21","author":"G Fanciulli","year":"2020","unstructured":"Fanciulli G, Ruggeri RM, Grossrubatscher E, Calzo FL, Wood TD, Faggiano A, et al. Serotonin pathway in carcinoid syndrome: clinical, diagnostic, prognostic and therapeutic implications. Rev Endocr Metab Disord. 2020;21:599\u2013612. https:\/\/doi.org\/10.1007\/s11154-020-09547-8.","journal-title":"Rev Endocr Metab Disord"},{"key":"7596_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/endrev\/bnad035","volume":"45","author":"MCF Mulders","year":"2024","unstructured":"Mulders MCF, de Herder WW, Hofland J. What is carcinoid syndrome? A critical appraisal of its proposed mediators. Endocr Rev. 2024;45:351\u201360. https:\/\/doi.org\/10.1210\/endrev\/bnad035.","journal-title":"Endocr Rev"},{"key":"7596_CR8","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","volume":"69","author":"J Davar","year":"2017","unstructured":"Davar J, Connolly HM, Caplin ME, Pavel M, Zacks J, Bhattacharyya S, et al. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017;69:1288\u2013304. https:\/\/doi.org\/10.1016\/j.jacc.2016.12.030.","journal-title":"J Am Coll Cardiol"},{"key":"7596_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043610","volume":"24","author":"G Vitale","year":"2023","unstructured":"Vitale G, Carra S, Alessi Y, Campolo F, Pandozzi C, Zanata I, et al. Carcinoid syndrome: preclinical models and future therapeutic strategies. Int J Mol Sci. 2023;24:3610. https:\/\/doi.org\/10.3390\/ijms24043610.","journal-title":"Int J Mol Sci"},{"key":"7596_CR10","doi-asserted-by":"publisher","first-page":"103959","DOI":"10.1016\/j.esmoop.2024.103959","volume":"9","author":"L Algeri","year":"2024","unstructured":"Algeri L, Falkman L, Spada F, Frassoni S, Bagnardi V, Boselli S, et al. Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers. ESMO Open. 2024;9:103959. https:\/\/doi.org\/10.1016\/j.esmoop.2024.103959.","journal-title":"ESMO Open"},{"key":"7596_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000381930","volume":"101","author":"S Grozinsky-Glasberg","year":"2015","unstructured":"Grozinsky-Glasberg S, Grossman AB, Gross DJ. Carcinoid heart disease: from pathophysiology to treatment\u2013\u2019something in the way it moves\u2019. Neuroendocrinology. 2015;101:263\u201373. https:\/\/doi.org\/10.1159\/000381930.","journal-title":"Neuroendocrinology"},{"issue":"12","key":"7596_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122966","volume":"14","author":"A Xu","year":"2022","unstructured":"Xu A, Suz P, Reljic T, Are AC, Kumar A, Powers B, et al. Perioperative carcinoid crisis: a systematic review and meta-analysis. Cancers (Basel). 2022;14(12):2966. https:\/\/doi.org\/10.3390\/cancers14122966.","journal-title":"Cancers (Basel)"},{"key":"7596_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40618-024-02448-6","volume":"48","author":"F Panzuto","year":"2025","unstructured":"Panzuto F, Albertelli M, De Rimini ML, Rizzo FM, Grana CM, Cives M, et al. Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM). J Endocrinol Invest. 2025;48:23\u201336. https:\/\/doi.org\/10.1007\/s40618-024-02448-6.","journal-title":"J Endocrinol Invest"},{"key":"7596_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40336-025-00679-y","author":"R Laudicella","year":"2025","unstructured":"Laudicella R, Albano D, Bauckneht M, Urso L, Bodei L, De Rimini ML, et al. Italian association of nuclear medicine, molecular imaging and therapy (AIMN) practical guide for peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-Oxodotreotide in gastroenteropancreatic neuroendocrine tumors (GEP-NET). Clin Transl Imaging. 2025. https:\/\/doi.org\/10.1007\/s40336-025-00679-y.","journal-title":"Clin Transl Imaging"},{"key":"7596_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2967\/jnumed.122.264860","volume":"64","author":"TA Hope","year":"2023","unstructured":"Hope TA, Allen-Auerbach M, Bodei L, Calais J, Dahlbom M, Dunnwald LK, et al. SNMMI procedure standard\/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors. J Nucl Med. 2023;64:204\u201310. https:\/\/doi.org\/10.2967\/jnumed.122.264860.","journal-title":"J Nucl Med"},{"key":"7596_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13060","volume":"34","author":"J Hofland","year":"2022","unstructured":"Hofland J, Lamarca A, Steeds R, Toumpanakis C, Srirajaskanthan R, Riechelmann R, et al. Synoptic reporting of echocardiography in carcinoid heart disease (ENETS carcinoid heart disease task force). J Neuroendocrinol. 2022;34:e13060. https:\/\/doi.org\/10.1111\/jne.13060.","journal-title":"J Neuroendocrinol"},{"key":"7596_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/BF03344149","volume":"29","author":"MV Dav\u00ec","year":"2006","unstructured":"Dav\u00ec MV, Bodei L, Francia G, Bartolomei M, Oliani C, Scilanga L, et al. Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). J Endocrinol Invest. 2006;29:563\u20137. https:\/\/doi.org\/10.1007\/BF03344149.","journal-title":"J Endocrinol Invest"},{"issue":"Supplement","key":"7596_CR18","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.4103\/jcrt.JCRT_22_18","volume":"16","author":"SK Yadav","year":"2020","unstructured":"Yadav SK, Jha CK, Patil S, Datta D, Mishra A, Pradhan PK. Lutetium therapy-induced carcinoid crisis: A case report and review of literature. J Cancer Res Ther. 2020;16(Supplement):S206\u20138. https:\/\/doi.org\/10.4103\/jcrt.JCRT_22_18.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"7596_CR19","first-page":"128","volume":"77","author":"L Siow Ping","year":"2022","unstructured":"Siow Ping L, Azraai BN, Subashini R. Peptide receptor radionuclide therapy induced carcinoid crisis: a case report. Med J Malaysia. 2022;77(1):128\u201331.","journal-title":"Med J Malaysia"},{"key":"7596_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jcrc.2020.08.011","volume":"60","author":"J Dhanani","year":"2020","unstructured":"Dhanani J, Pattison DA, Burge M, Williams J, Riedel B, Hicks RJ, et al. Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): a case report. J Crit Care. 2020;60:319\u201322. https:\/\/doi.org\/10.1016\/j.jcrc.2020.08.011.","journal-title":"J Crit Care"},{"key":"7596_CR21","doi-asserted-by":"publisher","unstructured":"Stenzel J, Noe S, Holzapfel K, Erlmeier F, Eyer F. Fatal systemic vasoconstriction in a case of metastatic small-intestinal NET. Case Rep Gastrointest Med. 2017;9810194. https:\/\/doi.org\/10.1155\/2017\/9810194.","DOI":"10.1155\/2017\/9810194"},{"key":"7596_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00259-007-0691-z","volume":"35","author":"B de Keizer","year":"2008","unstructured":"de Keizer B, van Aken MO, Feelders RA, de Herder WW, Kam BL, van Essen M, et al. Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate. Eur J Nucl Med Mol Imaging. 2008;35:749\u201355. https:\/\/doi.org\/10.1007\/s00259-007-0691-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7596_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2018.03.002","volume":"66","author":"G Tapia Rico","year":"2018","unstructured":"Tapia Rico G, Li M, Pavlakis N, Cehic G, Price TJ. Prevention and management of carcinoid crises in patients with high-risk neuroendocrine tumours undergoing peptide receptor radionuclide therapy (PRRT): literature review and case series from two Australian tertiary medical institutions. Cancer Treat Rev. 2018;66:1\u20136. https:\/\/doi.org\/10.1016\/j.ctrv.2018.03.002.","journal-title":"Cancer Treat Rev"},{"key":"7596_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13423","volume":"36","author":"A Lamarca","year":"2024","unstructured":"Lamarca A, Bartsch DK, Caplin M, Kos-Kudla B, Kjaer A, Partelli S, et al. European neuroendocrine tumor society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours. J Neuroendocrinol. 2024;36:e13423. https:\/\/doi.org\/10.1111\/jne.13423.","journal-title":"J Neuroendocrinol"},{"key":"7596_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2967\/jnmt.118.210179","volume":"46","author":"S Ramesh","year":"2018","unstructured":"Ramesh S, Kudachi S, Basu S. Peptide receptor radionuclide therapy with 177Lu-DOTATATE in carcinoid heart disease: a contraindication or a promising treatment approach bettering chances for corrective surgery? J Nucl Med Technol. 2018;46:292\u20134. https:\/\/doi.org\/10.2967\/jnmt.118.210179.","journal-title":"J Nucl Med Technol"},{"key":"7596_CR26","doi-asserted-by":"publisher","first-page":"e3665","DOI":"10.1210\/clinem\/dgab289","volume":"106","author":"WT Zandee","year":"2021","unstructured":"Zandee WT, Brabander T, Bla\u017eevi\u0107 A, Minczeles NS, Feelders RA, de Herder WW, et al. peptide receptor radionuclide therapy with 177Lu-DOTATATE for symptomatic control of refractory carcinoid syndrome. J Clin Endocrinol Metab. 2021;106:e3665\u201372. https:\/\/doi.org\/10.1210\/clinem\/dgab289.","journal-title":"J Clin Endocrinol Metab"},{"key":"7596_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072203","volume":"9","author":"MI Del Olmo-Garc\u00eda","year":"2020","unstructured":"Del Olmo-Garc\u00eda MI, Muros MA, L\u00f3pez-de-la-Torre M, Agudelo M, Bello P, Soriano JM, et al. Prevention and management of hormonal crisis during theragnosis with LU-DOTA-TATE in neuroendocrine tumors. A systematic review and approach proposal. J Clin Med. 2020;9:2203. https:\/\/doi.org\/10.3390\/jcm9072203.","journal-title":"J Clin Med"},{"key":"7596_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000526848","volume":"113","author":"M Li","year":"2023","unstructured":"Li M, Chan DL, Tapia Rico G, Cehic G, Lawrence B, Wyld D, et al. Australasian consensus statement on the identification, prevention, and management of hormonal crises in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy. Neuroendocrinology. 2023;113:281\u20138. https:\/\/doi.org\/10.1159\/000526848.","journal-title":"Neuroendocrinology"},{"key":"7596_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/bja\/87.3.447","volume":"87","author":"MA Kinney","year":"2001","unstructured":"Kinney MA, Warner ME, Nagorney DM, Rubin J, Schroeder DR, Maxson PM, et al. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. Br J Anaesth. 2001;87:447\u201352. https:\/\/doi.org\/10.1093\/bja\/87.3.447.","journal-title":"Br J Anaesth"},{"key":"7596_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jclinane.2016.03.008","volume":"32","author":"EA Woltering","year":"2016","unstructured":"Woltering EA, Wright AE, Stevens MA, Wang YZ, Boudreaux JP, Mamikunian G, et al. Development of effective prophylaxis against intraoperative carcinoid crisis. J Clin Anesth. 2016;32:189\u201393. https:\/\/doi.org\/10.1016\/j.jclinane.2016.03.008.","journal-title":"J Clin Anesth"},{"key":"7596_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060910","volume":"8","author":"L Magi","year":"2019","unstructured":"Magi L, Mazzuca F, Rinzivillo M, Arrivi G, Pilozzi E, Prosperi D, et al. Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center. J Clin Med. 2019;8:910. https:\/\/doi.org\/10.3390\/jcm8060910.","journal-title":"J Clin Med"},{"key":"7596_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07212-3","author":"N Poterszman","year":"2025","unstructured":"Poterszman N, Baltzinger P, MamulashviliBessac D, Pham Van F, Goichot B, Mertz L, et al. Neuroendocrine peritoneal disease and [177Lu]DOTATATE peptide receptor radionuclide therapy: a therapeutic challenge with potential clinical complications. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07212-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7596_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12674","author":"JE Dominguez-Mu\u00f1oz","year":"2024","unstructured":"Dominguez-Mu\u00f1oz JE, Vujasinovic M, de la Iglesia D, Cahen D, Capurso G, Gubergrits N, et al. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations. United Eur Gastroenterol J. 2024. https:\/\/doi.org\/10.1002\/ueg2.12674.","journal-title":"United Eur Gastroenterol J"},{"key":"7596_CR34","doi-asserted-by":"publisher","unstructured":"Grozinsky-Glasberg S, Hofland J, Alband S, de Lima YC, Croitoru A, Geilvoet W, Igaz P, Kos-Kud\u0142a B, Krejs GJ, Laviano A, Panzuto F, Sadanandam A, Santos AP, Welin S, Srirajaskanthan R. Controversies in NEN: an ENETS position statement on nutritional support in neuroendocrine neoplasms. J Neuroendocrinol. 2025; e70062. Advance online publication. https:\/\/doi.org\/10.1111\/jne.70062.","DOI":"10.1111\/jne.70062"},{"key":"7596_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102560","volume":"117","author":"A La Salvia","year":"2023","unstructured":"La Salvia A, Modica R, Rossi RE, Spada F, Rinzivillo M, Panzuto F, et al. Targeting neuroendocrine tumors with octreotide and lanreotide: key points for clinical practice from NET specialists. Cancer Treat Rev. 2023;117:102560. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102560.","journal-title":"Cancer Treat Rev"},{"key":"7596_CR36","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1136\/heartjnl-2017-311261","volume":"103","author":"SA Hassan","year":"2017","unstructured":"Hassan SA, Banchs J, Iliescu C, Dasari A, Lopez-Mattei J, Yusuf SW. Carcinoid heart disease. Heart. 2017;103:1488\u201395. https:\/\/doi.org\/10.1136\/heartjnl-2017-311261.","journal-title":"Heart"},{"issue":"16","key":"7596_CR37","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(16):3415\u2013537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177.","journal-title":"Eur Heart J"},{"issue":"12","key":"7596_CR38","doi-asserted-by":"publisher","first-page":"E1880","DOI":"10.1210\/jc.2013-1987","volume":"98","author":"R van der Pas","year":"2013","unstructured":"van der Pas R, Feelders RA, Gatto F, de Bruin C, Pereira AM, van Koetsveld PM, et al. Preoperative normalization of cortisol levels in Cushing\u2019s disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonists. J Clin Endocrinol Metab. 2013;98(12):E1880\u201390. https:\/\/doi.org\/10.1210\/jc.2013-1987.","journal-title":"J Clin Endocrinol Metab"},{"key":"7596_CR39","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1530\/EC-19-0413","volume":"8","author":"R Steeds","year":"2019","unstructured":"Steeds R, Sagar V, Shetty S, Oelofse T, Singh H, Ahmad R, et al. Multidisciplinary team management of carcinoid heart disease. Endocr Connect. 2019;8:R184\u201399. https:\/\/doi.org\/10.1530\/EC-19-0413.","journal-title":"Endocr Connect"},{"issue":"5","key":"7596_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bjane.2021.03.015","volume":"73","author":"NJ Vinzant","year":"2023","unstructured":"Vinzant NJ, Laporta ML, Sprung J, Atwell TD, Reisenauer CJ, Welch TL, et al. Hemodynamic course during ablation and selective hepatic artery embolization for metastatic liver carcinoid: a retrospective observational study. Brazilian Journal of Anesthesiology (English Edition). 2023;73(5):603\u201310. https:\/\/doi.org\/10.1016\/j.bjane.2021.03.015.","journal-title":"Brazilian Journal of Anesthesiology (English Edition)"},{"key":"7596_CR41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.surg.2015.05.036","volume":"159","author":"ME Condron","year":"2016","unstructured":"Condron ME, Pommier SJ, Pommier RF. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis. Surgery. 2016;159:358\u201365. https:\/\/doi.org\/10.1016\/j.surg.2015.05.036.","journal-title":"Surgery"},{"key":"7596_CR42","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1245\/s10434-023-14876-4","volume":"31","author":"BH McCully","year":"2024","unstructured":"McCully BH, Kozuma K, Pommier S, Pommier RF. Comparison of octreotide and vasopressors as first-line treatment for intraoperative carcinoid crisis. Ann Surg Oncol. 2024;31:2996\u20133002. https:\/\/doi.org\/10.1245\/s10434-023-14876-4.","journal-title":"Ann Surg Oncol"},{"key":"7596_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/cancers14030662","volume":"14","author":"C Bardasi","year":"2022","unstructured":"Bardasi C, Benatti S, Luppi G, Garajov\u00e0 I, Piacentini F, Dominici M, et al. Carcinoid crisis: a misunderstood and unrecognized oncological emergency. Cancers. 2022;14:662. https:\/\/doi.org\/10.3390\/cancers14030662.","journal-title":"Cancers"},{"key":"7596_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.endien.2024.03.020","volume":"71","author":"F Guerrero-P\u00e9rez","year":"2024","unstructured":"Guerrero-P\u00e9rez F, Peir\u00f3 I, Vercher-Conejero JL, Teul\u00e9 A, Villabona C. Carcinoid crisis: the challenge is still there. Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed). 2024;71:263\u201370. https:\/\/doi.org\/10.1016\/j.endien.2024.03.020.","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed)"},{"issue":"66","key":"7596_CR45","doi-asserted-by":"publisher","first-page":"990","DOI":"10.2967\/jnumed.124.268522","volume":"1","author":"A Mench","year":"2025","unstructured":"Mench A, Winters C, Mittra E, Szidonya L, Hess C, Barbon D, et al. Navigating radiation safety after radiopharmaceutical therapies: proposed workflow and essential guidelines for nonspecialists. J Nucl Med. 2025;1(66):990\u20134. https:\/\/doi.org\/10.2967\/jnumed.124.268522.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07596-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07596-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07596-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:42:56Z","timestamp":1769834576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07596-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7596"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07596-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a practical guide and therefore no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for the publication of images was received from the participants who appeared in the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}